PHBN Stock Overview

Manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. More details

PHBN fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	3/6
Financial Health	5/6
Dividends	4/6

Rewards

Trading at 10% below our estimate of its fair value

Earnings are forecast to grow 11.23% per year

Risk Analysis

Shares are highly illiquid

Unstable dividend track record

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Sonova Holding AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sonova Holding
Historical stock prices
Current Share Price	CHF 301.70
52 Week High	CHF 299.30
52 Week Low	CHF 280.90
Beta	1.04
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-79.19%

Recent updates

Shareholder Returns

	PHBN	DE Medical Equipment	DE Market
7D	6.5%	1.2%	0.5%
1Y	n/a	-9.0%	14.4%

Return vs Industry: Insufficient data to determine how PHBN performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how PHBN performed against the German Market.

Price Volatility

Is PHBN's price volatile compared to industry and market?
PHBN volatility
PHBN Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.4%
Market Average Movement	6.5%
10% most volatile stocks in DE Market	12.8%
10% least volatile stocks in DE Market	3.1%

Stable Share Price: PHBN's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine PHBN's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1947	18,351	Arnd Kaldowski	www.sonova.com

Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.

Sonova Holding AG Fundamentals Summary

How do Sonova Holding's earnings and revenue compare to its market cap?
PHBN fundamental statistics
Market cap	€17.93b
Earnings (TTM)	€575.10m
Revenue (TTM)	€4.11b

31.2x

P/E Ratio

4.4x

P/S Ratio

Is PHBN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHBN income statement (TTM)
Revenue	CHF 3.87b
Cost of Revenue	CHF 1.07b
Gross Profit	CHF 2.80b
Other Expenses	CHF 2.26b
Earnings	CHF 540.50m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Nov 14, 2025

Earnings per share (EPS)	9.07
Gross Margin	72.43%
Net Profit Margin	13.98%
Debt/Equity Ratio	56.3%

How did PHBN perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

49%

Payout Ratio

Does PHBN pay a reliable dividends?

See PHBN dividend history and benchmarks

When do you need to buy PHBN by to receive an upcoming dividend?
Sonova Holding dividend dates
Ex Dividend Date	Jun 13 2025
Dividend Pay Date	Jun 17 2025
Days until Ex dividend	24 days
Days until Dividend pay date	28 days

Does PHBN pay a reliable dividends?

See PHBN dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/19 21:20
End of Day Share Price	2025/05/19 00:00
Earnings	2025/03/31
Annual Earnings	2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sonova Holding AG is covered by 39 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Alexander Kleban	Barclays
Hassan Al-Wakeel	Barclays
Thomas Jones	Berenberg

Sonova Holding XTRA:PHBN Stock Report